William Pridgen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Virios Therapeutics, Inc. (NASDAQ: VIRI), a biotechnology company focused on advancing groundbreaking antiviral treatments for chronic conditions like fibromyalgia and Long-COVID, has experienced significant momentum over the past six months. At its peak, the company's stock surged by over 600%. While recent market fluctuations have caused a dip from these record highs, Virios is once

Virios Therapeutics’ Study Featured in Peer-Reviewed Journal Publication Highlighting Association of Herpes Simplex Type 1 Viral Infection with Common Gastrointestinal Disorders - read this article along with other careers information, tips and advice on BioSpace

Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Rating) – Analysts at Zacks Investment Research lifted their FY2022 earnings estimates for shares of Virios Therapeutics in a research note issued to investors on Tuesday, May 17th. Zacks Investment Research analyst D. Bautz now forecasts that the company will post earnings per share of ($2.02) for the year, […]

The names of three people found dead in a house fire in Delta over the weekend have been released.

Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Rating) Director William Pridgen acquired 2,197 shares of the company’s stock in a transaction that occurred on Wednesday, March 23rd. The shares were bought at an average cost of $5.46 per share, for a total transaction of $11,995.62. The transaction was disclosed in a document filed with the SEC, […]